YMYuanyuan Ma

Yuanyuan Ma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yuanyuan Ma has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Peng Xue

    Nantong University

    9 shared publications
  • Xinyuan Zhao

    Department of Occupational Medicine and Environmental Toxicology, Nantong Key Laboratory of Environmental Toxicology, School of Public Health, Nantong University, Nantong, 226019, China

    5 shared publications
  • Liuyang Cai

    Department of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Shanghai Changzheng Hospital, Naval Medical University, China

    3 shared publications
  • Wanqing Liao

    Department of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Shanghai Changzheng Hospital, Naval Medical University

    3 shared publications
  • Wenxia Bu

    Nantong Key Laboratory of Environmental Toxicology, Institute for Applied Research in Public Health, School of Public Health, Nantong University, Nantong, China

    3 shared publications
  • Bin Xu

    Jiangxi Key Laboratory of Oncology(2024SSY06041), JXHC Key Laboratory of Tumor Metastasis, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China

    2 shared publications

Latest Publications

  • Open Access

    Mitochondrial characteristics of echinocandin tolerance and resistance in Candida glabrata and Candida krusei

    by Peng Xue, Li Zhang, Mingwei Du, Quan Yuan, Haiyang He, Xiaochun Xue, Wanqing Liao, Yuanyuan Ma, Weihua Pan, Liuyang Cai

    Background: Candidiasis, especially candidemia, is one of the most common invasive fungal infections. With the increase of risk factors such as tumors, its high incidence and high mortality rate pose a significant challenge to public health. Echinocandins, as first-line drugs for candidemia, have their clinical efficacy severely weakened by the emergence of tolerant or resistant strains such as Candida glabrata and Candida krusei . Methods: The study evaluated the changes in mitochondrial phenotype (intracellular ATP levels, mitochondrial membrane potential, mitochondrial superoxide levels, and intracellular ROS levels), proteomic, metabolomic, and genomic in C. glabrata and C. krusei . Results: By analyzing strains with different susceptibility profiles, the study found that echinocandin tolerant or resistant strains displayed significant upregulation of ATP levels and unique metabolic adaptations. Quantitative proteomics identified differentially expressed proteins associated with mitochondrial function and energy metabolism. Metabolomic analysis further revealed distinct profiles linking resistance to alterations in purine metabolism and oxidative phosphorylation. Additionally, genomic sequencing of the resistant strains highlighted mutations in key genes involved in ATP binding. Conclusion: These findings highlight the mitochondrial characteristics in echinocandin tolerance and resistance in C. glabrata and C. krusei , providing valuable insights into potential pathways for future therapeutic interventions targeting resistant Candida species.


  • Open Access

    Candida albicans-Based Immune Training to Reduce Lung Fibrosis from Polystyrene Nanoparticles

    by Zhuyun Zhu, Yifan Zhou, Dongnan Zheng, Zemin Xu, Yuqing Chen, Fengxu Wang, Xinyuan Zhao, Yuanyuan Ma

    Polystyrene nanoparticles (PS-NPs) present significant risks to respiratory health, contributing to lung fibrosis. Current therapeutic strategies for PS-NP exposure injuries are limited and often ineffective. One promising solution is immunological training. This study explores the novel role of Candida albicans in immune training to alleviate PS-NP-induced fibrosis. Our findings demonstrate that C. albicans enhances immune responses in a unique way, advancing current frameworks of trained immunity and offering new therapeutic approaches for health issues related to environmental pollutants. We conducted experiments using male BALB/c mice exposed to 80 nm PS-NPs via posterior pharyngeal drip. Prior to exposure, the mice received an intravenous injection of low-dose C. albicans to induce immunological training. To evaluate the protective effects of C. albicans, we assessed survival rates, pulmonary histopathology, and gene expression profiles. The results indicated that while 100% of the control group exposed to PS-NPs did not survive, the group pre-treated with C. albicans exhibited complete survival. Histopathological analysis revealed preserved lung architecture and a significant reduction in collagen deposition in the C. albicans + PS-NPs group compared to the PS-NPs only group. Additionally, RNA sequencing analysis identified a total of 415 differentially expressed genes, including five upregulated circadian rhythm genes (Per3: 1.93-fold, Rorc: 1.69-fold, Cry1: 2.01-fold, Per1: 2.55-fold, Per2: 2.73-fold) and one downregulated circadian rhythm gene (Npas2: 0.42-fold) in the C. albicans + PS-NPs group compared to the PS-NPs group. C. albicans-based immune training reduces lung fibrosis and enhances survival after PS-NP exposure, suggesting a promising therapeutic strategy.


  • Open Access

    The kinases Hsl101 and Urk1 regulate metabolism of Cryptococcus neoformans

    by Yuanyuan Ma, Yetong Shen, Lei Zhang, Wenjie Fang, Weihua Pan, Wanqing Liao, Xin Ye, Xinyao Liu, Yanyan Xu, Xiaojing Li, et al.

    Cryptococcus neoformans is a significant human fungal pathogen, particularly concerning for immunocompromised individuals. Key kinases, Hsl101 and Urk1, are critical for crossing the blood-brain barrier, although the specific mechanisms by which they do so remain undefined. In this study, we systematically investigate the impact of HSL101 or URK1 deletion on the proteomic and metabolomic profiles of C. neoformans. By generating a deletion mutant for HSL101, we observed profound alterations in the expression levels of 366 proteins and 421 metabolites, highlighting significant disruptions in key biological processes, such as oxidative phosphorylation and ATP synthesis, which are vital for energy production in the cell. Similarly, the deletion of URK1 resulted in significant changes in the expression of 236 proteins and 366 metabolites, particularly affecting pathways related to steroid biosynthesis and starch and sucrose metabolism, which are critical for cellular function and adaptation. These findings shed light on the regulatory roles of Hsl101 and Urk1 in the metabolic pathways of C. neoformans.

  • Open Access

    The very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase Phs1 regulates ATP levels and virulence in Cryptococcus neoformans

    by Yuanyuan Ma, Kaisu Pan, Bin Xu, Wenjie Fang, Weihua Pan, Wanqing Liao, Cunwei Cao, Peng Xue, Liuyang Cai

    Cryptococcus neoformans is a significant fungal pathogen that poses a serious threat to immunocompromised individuals, particularly those with HIV/AIDS. In

  • Open Access

    Polystyrene nanoparticles reduce the Cryptococcus neoformans virulence via induction of mitochondrial dysfunction

    by Dongnan Zheng, Yifan Zhou, Bin Xu, Wenxia Bu, Fengxu Wang, Xinyuan Zhao, Peng Xue, Yuanyuan Ma

    Introduction: Cryptococcus neoformans is a fungus that poses a significant threat to human health, with its polysaccharide capsule being a key virulence factor that can upregulate the expression of host gene ARG1 , encoding arginase-1, which suppresses T-cell-mediated antifungal immune responses. Nanoplastics may cause oxidative and mitochondrial stress in mammalian cells, potentially impacting fungal physiology and pathogenic mechanisms as well. Methods: We utilized mouse models and fungal burden assays to investigate the effects of polystyrene nanoparticles (PS-NPs) on C. neoformans infection. Mice were subjected to oropharyngeal aspiration of 50 μl of 80 nm PS-NPs at a concentration of 5 μg/μl, administered three times a week over a specified duration. To assess the impact of PS-NPs on C. neoformans mitochondria, we measured intracellular reactive oxygen species (ROS) levels, mitochondrial superoxide, mitochondrial membrane potential, and intracellular ATP levels in whole fungal cells. Additionally, we performed RNA-Seq analysis and metabolomics studies to evaluate the effects of PS-NPs at a concentration of 0.3 μg/μL on the RNA and metabolic profiles of C. neoformans mitochondria. Results: Our study demonstrated that PS-NPs significantly prolonged the survival of mice infected with C. neoformans ( P = 0.0058). PS-NPs exposure resulted in a 30% reduction in ARG1 mRNA expression and enhanced T-cell-mediated antifungal immunity. Additionally, PS-NPs inhibited fungal capsule formation by approximately 40% in infected mice and 70% in capsule induction medium. Given the close link between the mitochondria of C. neoformans and capsule formation, we further investigated the effects of PS-NPs on mitochondrial function. Exposure to PS-NPs led to mitochondrial dysfunction in C. neoformans , as evidenced by a threefold increase in ROS, a 1.7-fold increase in mitochondrial membrane potential, and disruptions in mitochondrial transcription and metabolism. Conclusion: These results suggest that PS-NPs inhibit the formation of the C. neoformans capsule, potentially by inducing mitochondrial dysfunction. Furthermore, the findings highlight the broader implications of PS-NPs on fungal virulence and the dynamics of host-pathogen interactions, underscoring their significance in advancing our understanding of these complex relationships.


  • Open Access

    Nanoplastics and fungi: exploring dual roles in degradation and pathogenicity

    by Yuanyuan Ma, Yifan Zhou, Dongnan Zheng, Wenxia Bu, Fengxu Wang, Xinyuan Zhao, Peng Xue

    Plastic pollution, particularly in the form of nanoplastics, represents a growing global environmental crisis with profound impacts on ecosystems and human health. This review investigates the multifaceted interactions between fungi and nanoplastics, highlighting fungi’s dual role in both the degradation of plastics and their potential pathogenicity. Fungi possess specialized enzymatic pathways, which empower them to effectively break down a variety of plastic materials, leading to innovative bioremediation approaches. However, the omnipresence of nanoplastics in the environment poses significant challenges, as they can adversely affect fungal physiology, altering metabolic processes, enhancing virulence, and potentially contributing to antifungal resistance. This review examines the mechanisms through which different fungal species degrade specific plastics while emphasizing the influence of nanoplastics on fungal metabolic pathways and collective community dynamics. It explores the adaptations fungi may exhibit in response to nanoplastic exposure, including changes in enzymatic activity and resistance mechanisms. Additionally, the review addresses the implications of nanoplastic exposure for the pathogenicity of fungi, particularly concerning their interactions with human hosts and resistance to antifungal treatments. By providing a thorough analysis of the current understanding of nanoplastics and fungi, this review calls for urgent research into the ecological consequences of these interactions and the potential for increasing antifungal resistance. Ultimately, this work aims to inform effective strategies for mitigating the dual threats of plastic pollution and fungal-related health issues.


  • Top Cited Papers
    Open Access

    AI in fungal drug development: opportunities, challenges, and future outlook

    by Yanjian Li, Yue Qiao, Yuanyuan Ma, Peng Xue, Chen Ding

    The application of artificial intelligence (AI) in fungal drug development offers innovative strategies to address the escalating threat of fungal infections and the challenge of antifungal resistance. This review evaluates the current landscape of fungal infections, highlights the limitations of existing antifungal therapies, and examines the transformative potential of AI in drug discovery and development. We specifically focus on how AI can enhance the identification of new antifungal agents and improve therapeutic strategies. Despite numerous opportunities for advancement, significant challenges remain, particularly regarding data quality, regulatory frameworks, and the complexities associated with the drug development process. This review aims to provide insights into recent advancements in AI technologies, their implications for the future of fungal drug development, and the necessary research directions to effectively leverage AI for improved patient outcomes.


  • Open Access

    Exploring Fungi Within the Human Gut Microbiota: Obstacles, Innovations, Therapeutic Applications and Prospects Ahead

    by Peng Xue, Chao Luo, Jiashu Li, Liang Yang, Yuanyuan Ma

    Review Exploring Fungi Within the Human Gut Microbiota: Obstacles, Innovations, Therapeutic Applications and Prospects Ahead Peng Xue 1,†, Chao Luo 2,†, Jiashu Li 3, Liang Yang 3,* and Yuanyuan Ma 1,* 1 Nantong Key Laboratory of Environmental Toxicology, Department of Occupational Medicine and Environmental Toxicology, School of Public Health, Nantong University, Nantong 226019, China 2 The People’s Hospital of Rugao, Affiliated Rugao Hospital of Xinglin College, Nantong University, Nantong 226500, China 3 School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China * Correspondence: yangl@sustech.edu.cn (L.Y.); myycsd@ntu.edu.cn (Y.M.) Received: 15 September 2024; Revised: 23 October 2024; Accepted: 23 October 2024; Published: 9 April 2025 Fungi in the human gut microbiota participate in the maintenance of health and regulation of physiological processes. This review examines the complex role of gut fungi, highlighting challenges such as diverse fungal populations, cultivation difficulties, and knowledge gaps in their functional roles. Recent advancements in metagenomics and metabolomics have enabled innovative investigations into fungal communities, revealing their influence on host metabolism and immune responses. Future research should address the existing knowledge gaps and explore the therapeutic applications of gut fungi. Interdisciplinary collaborations and new methodologies are proposed to enhance the current understanding of fungi-host interactions, ultimately improving health outcomes and guide the development of novel treatment strategies. This review emphasizes the need to integrate fungal research into microbiome studies to provide a comprehensive understanding of gut health.

  • Open Access

    Nanoplastics and Fungi: Exploring Dual Roles in Degradation and Pathogenicity

    by Yuanyuan Ma, Yifan Zhou, Dongnan Zheng, Wenxia Bu, Fengxu Wang, Xinyuan Zhao, Peng Xue

    Plastic pollution, particularly in the form of nanoplastics, has emerged as a significant global environmental concern, affecting ecosystems and human health. This review examines the complex interactions between fungi and nanoplastics, emphasizing the dual role of fungi in plastic degradation and potential pathogenicity. Fungi possess unique enzymatic machinery that allows them to degrade various plastic materials, offering promising bioremediation strategies. However, the presence of nanoplastics can impact fungal physiology, potentially altering metabolic pathways, enhancing virulence, and contributing to antifungal resistance. The interactions between nanoplastics and fungi raise critical questions about their ecological roles and implications for human health. This review underscores the need for further research into the mechanisms of nanoplastic-fungi interactions, the effects on fungal communities, and the potential for increased resistance to antifungal agents. Understanding these dynamics is essential for developing effective strategies to address the challenges posed by plastic pollution and fungal infections. The findings highlight the importance of interdisciplinary approaches in addressing the intertwined issues of environmental sustainability and public health.

  • Gender-specific effects of prenatal polystyrene nanoparticle exposure on offspring lung development

    by Wenxia Bu, Mengjiao Yu, Xinyi Ma, Zhaoping Shen, Jialing Ruan, Yi Qu, Ruiyao Huang, Peng Xue, Yuanyuan Ma, Juan Tang, et al.